Abiopharma

Holdings of interested parties/officers as of 31.3.26

Report of control means as of 31.3.26

Akari Therapeutics Reports Positive Preclinical Data for AKTX-101 Demonstrating Differentiated Cytotoxicity for First-in-Class TROP2 ADC Payload Targeting RNA Splicing

Net Asset Value(s)

Integra LifeSciences to Host First Quarter 2026 Financial Results Conference Call on May 5, 2026

1847 Holdings Subsidiary Wolo Receives Approval of Amazon Brand Registry, Expanding E-Commerce Presence

CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026

Race Day Starts Before You Get to the Track: StubHub and New Era Team Up for F1’s North American Season and Beyond

Caris Life Sciences to Report First Quarter 2026 Financial Results on May 7, 2026

Late April Is the Best Time to List a Home For Sale